FDA will consider Pfizer vaccine for emergency use on December 10th

Will employers require workers to get coronavirus vaccine? FOX Business’ Gerri Willis on how workers and workplaces will be impacted when the coronavirus vaccine is released. The Food & Drug Administration announced Friday that its committee on vaccines will meet Dec. 10th to review Pfizer's request for emergency use authorization (EUA) of its Covid-19 vaccine. Continue Reading […]

Pre-market Movers In Healthcare Sector: DRAD, SUPN, ARGX, AZN, APVO…

What’s moving these stocks in the pre-market hours today? In the Green 1. Digirad Corporation (DRAD) is up over 25% at $3.20 in pre-market trading Wednesday, following news that it has entered into a Stock Purchase Agreement to sell its DMS Health Technologies Inc. business unit for $18.75 million. The deal is expected to close […]

Pre-market Movers In Healthcare Sector: CDNA, IMTX, REGN, CRSP, TLC…

What’s moving these stocks in the pre-market hours today? In the Green 1. AgeX Therapeutics Inc. (AGE) is up over 38% at $1.17 in pre-market trading Thursday. The company is focused on developing and commercializing innovative therapeutics for human aging. 2. Protagonist Therapeutics Inc. (PTGX), a clinical stage biopharmaceutical company, is up over 15% at […]

Pre-market Movers In Healthcare Sector: POAI, ACET, GNCA, WVE, NAOV…

What’s moving these stocks in the pre-market hours today? In the Green 1. Predictive Oncology Inc. (POAI) is up over 44% at $1.22 in pre-market trading Wednesday, following news of securing a license for an additional 71 unique ovarian cancer cell lines from UK-based Ximbio, the world’s largest non-profit dedicated to life science reagents of […]

ABIO Joins Battle Against COVID-19, ERYP On Watch, LPCN To Report NASH Study Results In Q1

Today’s Daily Dose brings you news about ARCA biopharma’s progress related to its COVID-19 drug candidate, ADC Therapeutics’ submission of Loncastuximab tesirine BLA, BridgeBio’s initiation of ADH1 study, ERYTECH Pharma’s anticipated milestones, and the progress in Lipocine’s NASH trial. Read on… 1. ARCA biopharma Joins battle Against COVID-19 ARCA biopharma Inc. (ABIO) has submitted an […]

MRNS Catches Eye, SAVA Soars On Alzheimer’s Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMU

Today’s Daily Dose brings you news about Gilead’s acquisition of Immunomedics, Marinus’ CDKL5 deficiency disorder trial results, Seattle Genetics’ oncology collaborations with Merck, 89bio’s NASH trial data, and Cassava Sciences’ Alzheimer’s trial results. Read on… 1. Cassava Sciences’ Alzheimer’s Trial Data Catches Eye Shares of Cassava Sciences Inc. (SAVA) were up 133% at $7.75 on […]

Innoviva Wins Another Key FDA Approval for Asthma

The U.S. Food and Drug Administration (FDA) has approved Innoviva Inc.’s (NASDAQ: INVA) treatment of asthma and for patients with chronic obstructive pulmonary disease (COPD), the company announced, giving shares a boost early Thursday. Specifically, the FDA has approved Innoviva’s Trelegy Ellipta for the treatment of asthma patients aged 18 years and older, adding to […]

AGTC Abuzz, AMRN Slumps & CORT Soars As Oral Arguments Commence, FLGT Gears Up, NNVC On Watch

Today’s Daily Dose brings you news about Applied Genetic’s upcoming presentation, oral arguments in patent suits of Amarin and Corcept, Fulgent’s partnership with New York City Health and Hospitals, NanoViricides’ update on COVID-19 drug development, and Sunesis Pharma’s reverse stock split, among others. Read on… 1. Applied Genetic Tech To present New data On Sep.9 […]

Pre-market Movers In Healthcare Sector: AIMT, HUGE, AMRN, EVFM, LPCN…

What’s moving these stocks in the pre-market hours today? In the Green 1. Aimmune Therapeutics Inc. (AIMT) is up over 170% at $34.03 in pre-market trading Monday as the company is all set to be acquired by Sociétés des Produits Nestlé S.A., part of Nestlé Health Science, for $34.50 per share in cash, representing a […]